The US Food and Drug Administration (FDA) is expected to approve the Pfizer / BioNTech vaccine against Covid-19 for children aged 5 to 11 years later today, the New York Times reported, citing people familiar with the agency's plans. .
The FDA decision will make this vaccine the first against Covid-19 approved for use in young children in the United States.
The approval is expected to make the Pfizer / BioNTech vaccine available to 28 million children – many of whom will return to school for life in the next few days
The expected FDA approval comes three days after a panel of the agency's expert advisors voted overwhelmingly in favor of using the Pfizer / BioNTech vaccine against Covid-19 for this solar group.
Source: politis.com.cy
